Early in the preclinical phase of AD, the shared biological pathways between MCI and T2D are mostly related to inflammation and infectious diseases, whereas later as the disease progresses, in AD–T2D, the insulin signaling becomes dysregulated and the cardiovascular system gets compromised. Here, INS is linked to Alzheimer disease.